Literature DB >> 8129768

Clinical significance of antibodies to native or denatured 60-kd or 52-kd Ro/SS-A proteins in Sjögren's syndrome.

K Tsuzaka, T Fujii, M Akizuki, T Mimori, T Tojo, H Fujii, Y Tsukatani, A Kubo, M Homma.   

Abstract

OBJECTIVE: To evaluate the clinical significance of antibodies to native or denatured (anti-n or anti-d) 60- or 52-kd Ro/SS-A proteins (60K or 52K) in Sjögren's syndrome (SS).
METHODS: The presence of antibodies to denatured and native Ro/SS-A proteins was determined by immunoblotting and immunoprecipitation, respectively. Salivary gland dysfunction was evaluated by salivary function scintigraphy.
RESULTS: The incidence of anti-d-60K without anti-d-52K was lower among patients with systemic lupus erythematosus with SS (SLE/SS) and among those with primary SS, compared with patients who had SLE without SS, whereas anti-d-52K without anti-d-60K was more common in SLE/SS patients and primary SS patients than in SLE patients without SS. All of the patients with anti-Ro/SS-A had anti-n-60K. Serologic abnormalities and salivary gland dysfunction were associated with anti-n-60K in SS, whereas Hashimoto's thyroiditis in SS was related to anti-d-60K. Anti-d-52K was not associated with any extraglandular or glandular symptoms in SS.
CONCLUSION: The data indicate that anti-n-60K, which appears to recognize conformational epitopes, is associated with clinical features of SS characterized by glandular dysfunction.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8129768     DOI: 10.1002/art.1780370113

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  7 in total

1.  Serum soluble Fas/APO-1 is increased in patients with primary Sjögren's syndrome.

Authors:  T Fujihara; T Takeuchi; K Tsubota; N Kayagaki; H Yagita; K Okumura; T Abe
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

2.  Ro/SS-A- and La/SS-B-reactive B lymphocytes in peripheral blood of patients with Sjögren's syndrome.

Authors:  A Halse; M Wahren-Herlenius; R Jonsson
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

3.  Purification of antigenically intact Ro ribonucleoproteins; biochemical and immunological evidence that the 52-kD protein is not a Ro protein.

Authors:  G Boire; M Gendron; N Monast; B Bastin; H A Ménard
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

4.  Serum samples of patients with rheumatoid arthritis contain a specific autoantibody to "denatured" aldolase A in the osteoblast-like cell line, MG-63.

Authors:  F Ukaji; I Kitajima; T Kubo; C Shimizu; T Nakajima; I Maruyama
Journal:  Ann Rheum Dis       Date:  1999-03       Impact factor: 19.103

5.  Anti-ribonucleoproteins autoantibodies in patients with systemic autoimmune diseases. Relation with cutaneous photosensitivity.

Authors:  Mariela L Paz; Daniel H González Maglio; María Pino; Alejandro Ferrari; Federico S Weill; Gustavo Nasswetter; Juliana Leoni
Journal:  Clin Rheumatol       Date:  2010-05-19       Impact factor: 2.980

6.  Clinical significances of antibodies to Ro/SS-A autoantigens and its subtypes in primary Sjögren's syndrome.

Authors:  C S Cho; S H Park; J K Min; S H Lee; H Y Kim
Journal:  Korean J Intern Med       Date:  1997-06       Impact factor: 2.884

7.  Diagnostic Utility of Separate Anti-Ro60 and Anti-Ro52/TRIM21 Antibody Detection in Autoimmune Diseases.

Authors:  Ailsa Robbins; Maxime Hentzien; Segolene Toquet; Kevin Didier; Amelie Servettaz; Bach-Nga Pham; Delphine Giusti
Journal:  Front Immunol       Date:  2019-03-12       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.